STAGING

1. ENDOMETRIAL CARCINOSARCOMA SARCOMA LMS/ESS OVARY ADENOSARCOMA I Ovaries A One B Both C Capsule, Ascites II Pelvis A Uterus, Tubes B Pelvic tissues C Capsule, Ascites III Peritoneum A Microscopic B <2cm C >2cm, Lymph Nodes IV Distant mets I Uterus A EM,<50% myometrium B >50% myometrium II Cervix Stroma III Pelvis A Serosa, Adnexa B Vagina, Parametria C LN (PPA) 1 Pelvic 2 Para Aortic IV Mets A Bladder/Bowel mucosa B DM I Uterus A <= 5 cm B > 5 cm II Pelvis A Adnexa B Other Pelvic tissues III Invades abdominal tissues A 1 Site B > 1 Site C LN IV Mets A Bladder/Rectum B DM I Uterus A <= 5 cm B > 5 cm II Pelvis A Adnexa B Other Pelvic tissues III Invades abdominal tissues A 1 Site B > 1 Site C LN IV Mets A Bladder/Rectum B DM CERVIX VULVA VAGINA MELANOMA I A 1 3d x 7w mm 2 3-5d x 7w mm B 1 <4cm 2 >4 cm II A1≤ 4 cm & upper vagina (<2/3) 2 > 4cm & upper vagina (<2/3) B parametria III A lower vagina (1/3) B pelvic side wall, hydro IV A Bladder/Bowel B DM I A < 1mm d x < 2cm w B > 1mm d or > 2cm w II any size, lower 1/3 urethra, vagina, anus, NEG LN IIIPOS inguino-femoral LN A 1 LN ≥ 5 mm Or, 1–2 LN < 5 mm B ≥ 2 LN ≥ mm Or, ≥ 3 LN < 5 mm C Extracapsular spread IV A upper urethra, mucosa bladder/bowel, pelvic bone Or, fixed or ulcerated inguino-femoral LN B Distant mets, Pelvic LN I Vaginal wall II Sub-vaginal tissue III Pelvic wall IV A Mucosa bladder/bowel, beyond true pelvis B DM (Clark) I In Situ, < basement mem II >BM into papillary dermis III Filling PD III >PD into reticular dermis IV into subcut fat STAGING